A detailed history of Deutsche Bank Ag\ transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 13,424 shares of SCPH stock, worth $44,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,424
Previous 13,424 -0.0%
Holding current value
$44,164
Previous $58,000 5.17%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.51 - $5.21 $3,187 - $4,730
-908 Reduced 6.34%
13,424 $58,000
Q1 2024

May 15, 2024

BUY
$4.86 - $6.39 $61,969 - $81,478
12,751 Added 806.51%
14,332 $71,000
Q4 2023

Feb 14, 2024

SELL
$4.7 - $6.63 $70,561 - $99,536
-15,013 Reduced 90.47%
1,581 $9,000
Q3 2023

Nov 09, 2023

BUY
$7.0 - $9.82 $17,955 - $25,188
2,565 Added 18.28%
16,594 $118,000
Q2 2023

Aug 14, 2023

BUY
$8.94 - $11.74 $125,419 - $164,700
14,029 New
14,029 $142,000
Q2 2021

Aug 11, 2021

SELL
$5.19 - $7.38 $23,329 - $33,173
-4,495 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$5.65 - $7.66 $2,423 - $3,286
-429 Reduced 8.71%
4,495 $29,000
Q4 2020

Feb 16, 2021

BUY
$5.17 - $9.41 $7,320 - $13,324
1,416 Added 40.36%
4,924 $26,000
Q3 2020

Nov 12, 2020

BUY
$7.12 - $8.86 $7,362 - $9,161
1,034 Added 41.79%
3,508 $26,000
Q2 2020

Aug 13, 2020

BUY
$7.01 - $10.96 $17,342 - $27,115
2,474 New
2,474 $18,000
Q1 2020

May 14, 2020

SELL
$5.4 - $10.45 $17,371 - $33,617
-3,217 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$4.1 - $6.21 $13,189 - $19,977
3,217 New
3,217 $18,000
Q3 2019

Nov 14, 2019

SELL
$3.24 - $7.35 $5,929 - $13,450
-1,830 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$2.48 - $3.76 $16,551 - $25,094
-6,674 Reduced 78.48%
1,830 $5,000
Q1 2019

May 15, 2019

SELL
$2.84 - $4.18 $1,388 - $2,044
-489 Reduced 5.44%
8,504 $25,000
Q4 2018

Feb 14, 2019

SELL
$3.76 - $5.61 $25,154 - $37,530
-6,690 Reduced 42.66%
8,993 $33,000
Q3 2018

Dec 21, 2021

BUY
$4.22 - $6.03 $7,587 - $10,841
1,798 Added 12.95%
15,683 $92,000
Q3 2018

Nov 14, 2018

BUY
$4.22 - $6.03 $346 - $494
82 Added 0.59%
13,885 $80,000
Q2 2018

Apr 21, 2020

BUY
$5.53 - $15.4 $11,369 - $31,662
2,056 Added 17.5%
13,803 $78,000
Q2 2018

Aug 14, 2018

BUY
$5.53 - $15.4 $12,647 - $35,219
2,287 Added 24.18%
11,747 $65,000
Q1 2018

Oct 18, 2019

BUY
$11.62 - $17.32 $19,626 - $29,253
1,689 Added 21.73%
9,460 $117,000
Q1 2018

May 15, 2018

BUY
$11.62 - $17.32 $90,299 - $134,593
7,771 New
7,771 $96,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $90.2M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.